Company Filing History:
4 out of 114 
1 out of 3,539 
1 out of 70 Years Active: 1988-2011
Title: The Innovations of Kunio Ohkuma
Introduction
Kunio Ohkuma is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of vaccine development, holding a total of 5 patents. His work focuses on improving vaccine safety and efficacy, particularly in relation to smallpox and influenza.
Latest Patents
Ohkuma's latest patents include a process for preparing a live smallpox vaccine. This innovative method provides a safer live smallpox vaccine with a reduced content of revertants. The process involves inoculating a master seed solution of an attenuated vaccinia virus into multiple containers of rabbit kidney cells, followed by incubation. Additionally, he has developed novel muramyldipeptide derivatives that serve as excellent adjuvants or components of virosome vaccines. These derivatives are incorporated into an influenza vaccine that demonstrates excellent antibody-producing capacity and safety.
Career Highlights
Throughout his career, Ohkuma has worked with esteemed organizations such as the Chemo-Sero-Therapeutic Research Institute and the National Institute of Health. His research has significantly advanced the understanding and development of vaccines, contributing to public health.
Collaborations
Ohkuma has collaborated with notable colleagues, including Tetsuya Oka and Tetsuo Kawahara. These partnerships have fostered innovation and enhanced the impact of his research in the field of immunology.
Conclusion
Kunio Ohkuma's contributions to vaccine development highlight his dedication to improving public health through innovative solutions. His patents reflect a commitment to safety and efficacy in vaccine technology.